Expert Commentary

Webcast: Oral contraceptives and breast cancer: What’s the risk?

OBG Manag. 2016 June;28(6)
By
Ronald T. Burkman, MD
Author and Disclosure Information

Does the use of oral contraceptives, particularly the presence of estrogen and progesterone, increase the risk of breast cancer? And what about a patient who has a BRCA gene mutation, is her risk altered by her genetic mutation? What the data tell us.

 

Access Dr. Burkman's Webcasts on contraception:

Helpful resource for your practice:

Recommended Reading

Effects of exercise interventions during different treatments in breast cancer
Breast Cancer ICYMI
Omission of dexamethasone from antiemetic treatment for highly emetogenic chemotherapy in breast cancer patients with hepatitis B infection or diabetes mellitus
Breast Cancer ICYMI
Paraneoplastic syndrome and underlying breast cancer: a worsening rash despite initiation of chemotherapy
Breast Cancer ICYMI
Investigational CDK4/6 inhibitor shows activity, less toxicity
Breast Cancer ICYMI
Targeting vagal activity could improve breast cancer survival
Breast Cancer ICYMI
Biosimilar trastuzumab comparable on safety, efficacy
Breast Cancer ICYMI
VIDEO: Dr. Rugo discusses regulatory future for trastuzumab biosimilar
Breast Cancer ICYMI
MONARCH 1: Abemaciclib is active in refractory HR+, HER2– breast cancer
Breast Cancer ICYMI
VIDEO: Doctors should be challenged to extend AIs
Breast Cancer ICYMI
Ethnic groups differ in BRCA risk management
Breast Cancer ICYMI

Related Articles